Compare GMTL & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GMTL | EMBC |
|---|---|---|
| Founded | 2021 | 1924 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 354.7M | 354.1M |
| IPO Year | 2024 | 2021 |
| Metric | GMTL | EMBC |
|---|---|---|
| Price | $3.86 | $5.86 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $25.50 | $4.00 |
| AVG Volume (30 Days) | 326.3K | ★ 692.1K |
| Earning Date | 12-01-2026 | 11-24-2026 |
| Dividend Yield | N/A | ★ 0.66% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.59 |
| P/E Ratio | ★ N/A | $5.89 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.76 | $2.77 |
| 52 Week High | $22.21 | $14.81 |
| Indicator | GMTL | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 31.25 | 42.37 |
| Support Level | N/A | $5.64 |
| Resistance Level | $5.73 | $6.85 |
| Average True Range (ATR) | 0.41 | 0.34 |
| MACD | 0.06 | -0.08 |
| Stochastic Oscillator | 5.81 | 16.83 |
Guardian Metal Resources PLC is mainly involved in the exploration and exploitation of mineral resources in the U.S. The group operated as a single operating and reportable segment, being the exploration and evaluation of mineral resources in Nevada, United States. Its projects are Pilot Mountain Project located in Nevada; Tempiute Project Located in south-central Nevada; Golconda Summit Project located in Nevada; Garfield Project located in Nevada; Kibby Basin Lithium Project located in Nevada; and Stonewall Project located in Nevada.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.